Hot Biotech Stocks For 2019

Standard Life Aberdeen plc bought a new stake in shares of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) during the 2nd quarter, HoldingsChannel.com reports. The institutional investor bought 9,802 shares of the biotechnology company’s stock, valued at approximately $923,000.

A number of other institutional investors also recently added to or reduced their stakes in the business. Palo Alto Investors LP increased its stake in BioMarin Pharmaceutical by 1.9% during the 1st quarter. Palo Alto Investors LP now owns 2,545,482 shares of the biotechnology company’s stock valued at $206,362,000 after buying an additional 47,676 shares during the period. USS Investment Management Ltd grew its stake in shares of BioMarin Pharmaceutical by 22.9% in the 1st quarter. USS Investment Management Ltd now owns 1,339,671 shares of the biotechnology company’s stock worth $111,869,000 after purchasing an additional 249,738 shares during the last quarter. Thrivent Financial for Lutherans grew its stake in shares of BioMarin Pharmaceutical by 581.0% in the 1st quarter. Thrivent Financial for Lutherans now owns 1,224,776 shares of the biotechnology company’s stock worth $99,293,000 after purchasing an additional 1,044,921 shares during the last quarter. Frontier Capital Management Co. LLC grew its stake in shares of BioMarin Pharmaceutical by 42.8% in the 2nd quarter. Frontier Capital Management Co. LLC now owns 1,210,472 shares of the biotechnology company’s stock worth $114,026,000 after purchasing an additional 362,531 shares during the last quarter. Finally, Fred Alger Management Inc. grew its stake in shares of BioMarin Pharmaceutical by 4.3% in the 2nd quarter. Fred Alger Management Inc. now owns 974,473 shares of the biotechnology company’s stock worth $91,795,000 after purchasing an additional 39,852 shares during the last quarter.

Hot Biotech Stocks For 2019: Liberty Property Trust(LPT)

Advisors’ Opinion:

  • [By Joseph Griffin]

    Get a free copy of the Zacks research report on Liberty Property Trust (LPT)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Max Byerly]

    DiamondRock Hospitality (NYSE:DRH) and Liberty Property Trust (NYSE:LPT) are both mid-cap finance companies, but which is the better investment? We will compare the two companies based on the strength of their risk, institutional ownership, analyst recommendations, earnings, profitability, valuation and dividends.

  • [By Logan Wallace]

    Retirement Systems of Alabama lifted its position in Liberty Property Trust (NYSE:LPT) by 4.5% during the 2nd quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 387,171 shares of the real estate investment trust’s stock after purchasing an additional 16,658 shares during the quarter. Retirement Systems of Alabama’s holdings in Liberty Property Trust were worth $17,163,000 at the end of the most recent quarter.

  • [By Shane Hupp]

    These are some of the media headlines that may have impacted Accern’s analysis:

    Get Liberty Property Trust alerts:

    Liberty Property Trust Announces Third Quarter 2018 Dividend (feeds.benzinga.com) Zacks: Brokerages Expect Liberty Property Trust (LPT) Will Announce Quarterly Sales of $160.48 Million (americanbankingnews.com) Liberty Property's The Navy Yard Portfolio Now 99% Leased (finance.yahoo.com) Zacks: Analysts Expect Liberty Property Trust (LPT) Will Announce Earnings of $0.65 Per Share (americanbankingnews.com) High Demand Keeps Liberty's Richmond, Norfolk Assets Occupied (finance.yahoo.com)

    Shares of LPT opened at $43.00 on Wednesday. The firm has a market cap of $6.36 billion, a price-to-earnings ratio of 16.60, a PEG ratio of 2.73 and a beta of 0.61. The company has a debt-to-equity ratio of 0.91, a current ratio of 1.76 and a quick ratio of 1.76. Liberty Property Trust has a twelve month low of $37.77 and a twelve month high of $45.40.

  • [By Stephan Byrd]

    Get a free copy of the Zacks research report on Liberty Property Trust (LPT)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Shane Hupp]

    DekaBank Deutsche Girozentrale lowered its position in shares of Liberty Property Trust (NYSE:LPT) by 11.7% during the first quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 12,176 shares of the real estate investment trust’s stock after selling 1,608 shares during the period. DekaBank Deutsche Girozentrale’s holdings in Liberty Property Trust were worth $515,000 as of its most recent SEC filing.

Hot Biotech Stocks For 2019: Destination Maternity Corporation(DEST)

Advisors’ Opinion:

  • [By Lisa Levin] Gainers
    Comstock Holding Companies, Inc. (NASDAQ: CHCI) shares climbed 154.95 percent to close at $5.15 on Thursday. Comstock reported conversion of the majority of its unsecured, short-term debt into non-convertible preferred equity.
    Tyme Technologies, Inc. (NASDAQ: TYME) jumped 33.45 percent to close at $3.87.
    Universal Corporation (NYSE: UVV) gained 29.72 percent to close at $62.85 after reporting fiscal Q4 results.
    Evolus, Inc. (NASDAQ: EOLS) shares rose 22.93 percent to close at $23.80.
    nLIGHT, Inc. (NASDAQ: LASR) jumped 21.52 percent to close at $36.37 following Q1 results.
    Hudson Technologies Inc. (NASDAQ: HDSN) gained 20.28 percent to close at $2.61.
    The Cato Corporation (NYSE: CATO) shares rose 19.57 percent to close at $21.45 after the company posted better-than-expected first-quarter results.
    AXT, Inc. (NASDAQ: AXTI) gained 18.8 percent to close at $7.90.
    Catasys, Inc. (NASDAQ: CATS) rose 16.33 percent to close at $6.41.
    HUYA Inc. (NYSE: HUYA) rose 15.68 percent to close at $23.09 on Thursday.
    Marinus Pharmaceuticals, Inc. (NASDAQ: MRNS) climbed 15.11 percent to close at $6.02 on Thursday after gaining 6.30 percent on Wednesday. Baird initiated coverage on Marinus Pharmaceuticals with an Outperform rating.
    Destination Maternity Corporation (NASDAQ: DEST) shares rose 14.48 percent to close at $3.32 after the board announced late Wednesday the election of four activist-backed director nominees. Three women and one man comprise the selected group championed by NGM Capital’s Nathan Miller and Kenosis Capital’s Peter O’Malley. Destination Maternity had advocated for another slate of three men and interim CEO Melissa Payner-Gregor. The new directors are Holly Alden, Marla Ryan, Anne-Charlotte Windal and Christopher Morgan.
    China Rapid Finance Limited (NYSE: XRF) gained 11.53 percent to close at $3.29 after announcing preliminary Q1 results.
    Bilibili Inc.. (NASDAQ: BILI) shares rose 11.33 pe
  • [By Lisa Levin]

    Destination Maternity Corporation (NASDAQ: DEST) shares were also up, gaining 15 percent to $3.343 after the board announced late Wednesday the election of four activist-backed director nominees. Three women and one man comprise the selected group championed by NGM Capital’s Nathan Miller and Kenosis Capital’s Peter O’Malley. Destination Maternity had advocated for another slate of three men and interim CEO Melissa Payner-Gregor. The new directors are Holly Alden, Marla Ryan, Anne-Charlotte Windal and Christopher Morgan.

  • [By Alexander Bird]

    Here are last week’s top-performing penny stocks:

    Penny Stock Current Share Price Last Week’s Gain
     Ambow Education Holdings Ltd. (NYSE: AMBO) $5.70 77.11%
    Nano Dimension (Nasdaq: NNDM) $2.61 75.11%
    Destination Maternity Corp. (Nasdaq: DEST) $5.79 71.84%
    CLPS Inc. (Nasdaq: CLPS) $9.72 71.15%
    NII Holdings Inc. (Nasdaq: NIHD) $3.20 56.33%
    Viveve Medical Inc. (Nasdaq: VIVE) $3.78 51.98%
    Galectin Therapeutics Inc. (Nasdaq: GALT) $9.18 41.82%
    Apricus Biosciences Inc. (Nasdaq: APRI) $0.36 34.70%
    Polymet Mining Corp. (NYSE: PLM) $1.01 31.13%
    Xenon Pharmaceuticals Inc. (Nasdaq: XENE) $8.20 28.46%

    Many investors struggle with finding stocks with this sort of breakout potential because they don’t know where to look.

  • [By Logan Wallace]

    Cato (NYSE: CATO) and Destination Maternity (NASDAQ:DEST) are both small-cap retail/wholesale companies, but which is the better stock? We will contrast the two companies based on the strength of their risk, dividends, valuation, institutional ownership, profitability, earnings and analyst recommendations.

  • [By Lisa Levin] Gainers
    Comstock Holding Companies, Inc. (NASDAQ: CHCI) shares surged 115.8 percent to $4.3591. Comstock reported conversion of the majority of its unsecured, short-term debt into non-convertible preferred equity.
    Stellar Biotechnologies, Inc. (NASDAQ: SBOT) jumped 38.2 percent to $3.0251 after the company disclosed that it achieved robust viral clearance for its manufacturing process.
    Universal Corporation (NYSE: UVV) surged 26.7 percent to $61.40 after reporting fiscal Q4 results.
    Hudson Technologies Inc. (NASDAQ: HDSN) rose 18.9 percent to $2.58.
    Evolus, Inc. (NASDAQ: EOLS) shares gained 17.8 percent to $22.8009.
    The Cato Corporation (NYSE: CATO) shares gained 17.5 percent to $21.07 after the company posted better-than-expected first-quarter results.
    Tyme Technologies, Inc. (NASDAQ: TYME) rose 15.9 percent to $3.3613.
    Destination Maternity Corporation (NASDAQ: DEST) shares gained 15.5 percent to $3.35 after the board announced late Wednesday the election of four activist-backed director nominees. Three women and one man comprise the selected group championed by NGM Capital’s Nathan Miller and Kenosis Capital’s Peter O’Malley. Destination Maternity had advocated for another slate of three men and interim CEO Melissa Payner-Gregor. The new directors are Holly Alden, Marla Ryan, Anne-Charlotte Windal and Christopher Morgan.
    AXT, Inc. (NASDAQ: AXTI) rose 15 percent to $7.65.
    nLIGHT, Inc. (NASDAQ: LASR) gained 14.5 percent to $34.27 following Q1 results.
    Achieve Life Sciences, Inc. (NASDAQ: ACHV) rose 14.3 percent to $11.4303.
    Bilibili Inc.. (NASDAQ: BILI) shares climbed 13.9 percent to $14.16 after announcing Q1 results.
    Babcock & Wilcox Enterprises, Inc. (NYSE: BW) gained 13.2 percent to $2.91 after an amended 13D filing from Steel Partners Holdings shows a raised stake in the company from 6.99 million shares to 29.98 million shares, or a 17.8 percent stake.
    HUYA Inc. (NYSE: HUYA) gained 13.1

Hot Biotech Stocks For 2019: Exxon Mobil Corporation(XOM)

Advisors’ Opinion:

  • [By Paul Ausick]

    Exxon Mobil Corp. (NYSE: XOM) traded up about 1.0% to $83.66, in a 52-week range of $72.16 to $89.30. Over the past 12 months, Exxon stock has traded up about 5.2%.

  • [By Logan Wallace]

    Get a free copy of the Zacks research report on Exxon Mobil (XOM)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Paul Ausick]

    Here’s how share prices of the largest U.S. natural gas producers reacted to the latest report:

    Exxon Mobil Corp. (NYSE: XOM), the country’s largest producer of natural gas, traded down less than 0.1% to $84.62, in a 52-week range of $72.16 to $89.30. Chesapeake Energy Corp. (NYSE: CHK) traded up about 1.6%, at $4.37 in a 52-week range of $2.53 to $5.60. EOG Resources Inc. (NYSE: EOG) traded down about 0.5% to $119.63. The 52-week range is $93.14 to $131.60.

    In addition, the United States Natural Gas ETF (NYSEARCA: UNG) traded up about 0.8%, at $23.96 in a 52-week range of $20.40 to $27.43.

  • [By Matthew DiLallo]

    ExxonMobil (NYSE:XOM) has been under pressure to do something to fix its sagging production, which slid 3% during the second quarter and impacted the company’s ability to cash in on higher oil prices. That led it to unveil a bold plan earlier this year that would see it boost its production up to 5 million barrels of oil equivalent per day (BOE/D) by 2025 — a 25% increase from its current level — and more than double its earnings and cash flow. One of the key fuels driving that growth is the Permian Basin, where Exxon expects to boost its output fivefold, to as much as 800,000 BOE/D.

  • [By Paul Ausick]

    Oil and gas supermajor Exxon Mobil Corp. (NYSE: XOM) announced Thursday that it has made another discovery offshore of Guyana, adding to an estimated 4 billion barrels of total resource the company already has uncovered in the area. The discovery announced today was drilled at the Hammerhead-1 well to a depth of nearly 14,000 feet under 3,373 feet of water. Drilling began on July 27.

Leave a Reply

Your email address will not be published. Required fields are marked *